FIELD: medicine; therapy.
SUBSTANCE: group of inventions can be used in treating COVID-19 infection. Method according to the invention involves oral administration of sodium polyprenyl phosphate in a daily dose of 40 mg and glycyrrhizic acid in a daily dose of 210 mg. According to the invention, the composition contains mixture of 40 mg of sodium polyprenyl phosphate and 210 mg of glycyrrhizic acid.
EFFECT: use of inventions enables to achieve higher clinical effectiveness with reduced risk of side effects, such as thrombosis, fluid retention, high blood pressure, due to synergetic interaction of polyprenols and glycyrrhizin derivative.
2 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEFLOQUINE AND COMBINATIONS THEREOF FOR TREATING AND PREVENTING A CORONAVIRUS INFECTION | 2020 |
|
RU2763024C1 |
| METHOD FOR PREVENTION OR TREATMENT OF CORONAVIRUS AND OTHER ACUTE RESPIRATORY VIRAL INFECTIONS | 2022 |
|
RU2794315C1 |
| USE OF A PHARMACEUTICAL COMPOSITION WITH ANTIOXIDANT, VIRUCIDAL, IMMUNOSTULATING, ANTIHYPOXIC AND ANTI-AGGREGANT EFFECT | 2023 |
|
RU2808445C1 |
| “ANTI-COVID” PROGRAM BY I. KRIVOPALOV-MOSKVIN - REHABILITATION OF PATIENTS AFTER CORONAVIRUS INFECTION CAUSED BY COVID-19 | 2022 |
|
RU2807167C2 |
| METHOD OF REDUCING RATE OF RECURRENCES AND INTENSITY OF SYMPTOMS OF GENITAL HERPES | 2014 |
|
RU2577718C1 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL DISEASES | 2021 |
|
RU2780252C1 |
| METHODS FOR TREATING INFECTIOUS DISEASES CAUSED BY CORONAVIRUS | 2021 |
|
RU2772701C1 |
| PREPARATION TO PREVENT AND TREAT INFECTIOUS DISEASES AND CORRECT PATHOLOGICAL STATES | 1998 |
|
RU2177788C2 |
| METHOD FOR PROTECTION AGAINST CORONAVIRUS INFECTION | 2020 |
|
RU2747467C1 |
| TECHNOLOGY OF REHABILITATION-PREVENTIVE NUTRITIONAL SUPPORT IN CORONAVIRUS INFECTION | 2020 |
|
RU2735723C1 |
